Progressive ratio

Progressive ratio, i.e. food-seeking constrained by escalating effort schedule. The last successfully completed ratio or shock intensity endured before timeout. Animals are food restricted to 85% of initial body weight, trained to lever-press for food pellets (45 mg) until stable response rates were reached, then tested either on the progressive ratio (PR) task with progressively increasing effort requirements (lever-presses required per pellet) or progressively increasing punishment (i.e., a foot-shock of increasing intensity presented 1 s after food pellet delivery, whose magnitude increases ~25% every 3 trials). In the PR task, rats time out if 2 min passed without a lever press. In the punishment task, a timeout is defined by three consecutive trials with >30 s passing without a lever press. For both tasks, the break point is the last successfully completed ratio or shock intensity endured before timeout.

Tags: Behavior · Motivation

Project: u01_tom_jhou

1 loci · 1 genes with independent associations · 1 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 10 62271668 63667097 1 1 1.28e-08 5.35e-01 4.48e-09 Eral1

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
Heart weight 3.63 1 0 0 0 1e+00 Eral1
Left kidney weight 1.53 1 0 0 0 1e+00 Eral1
Food consumed during 24 hour testing period 14.68 1 0 0 0 1e+00 Eral1
Times rat made contact with spout 19.64 1 0 0 0 1e+00 Eral1
Mean time between licks in bursts 5.57 1 0 0 0 1e+00 Eral1
Mean num. licks in bursts 16.6 1 0 0 0 1e+00 Eral1
Std. dev. time between licks in bursts 13.88 1 0 0 0 1e+00 Eral1
Intermittent access intake escalation 2 6.45 1 0 0 0 1e+00 Eral1
Intermitt. access day 1 inactive lever presses 5.81 1 0 0 0 1e+00 Eral1
Intermitt. access day 15 inactive lever presses 19.83 1 0 0 0 1e+00 Eral1
Intermittent access total locomotion 7.32 1 0 0 0 1e+00 Eral1
Short access day 10 total inactive lever presses 4.2 1 0 0 0 1e+00 Eral1
Short access day 1 total infusions 28.54 1 1 100 0 1e+00 Eral1
Short access total infusions 17.56 1 0 0 0 1e+00 Eral1
Short access day 1 locomotion 23.22 1 0 0 0 1e+00 Eral1
Short access total locomotion 23.77 1 0 0 0 1e+00 Eral1
Breakpoint value in progressive ratio session 7.34 1 0 0 0 1e+00 Eral1
Distance traveled before self-admin 58.43 1 1 100 0 1e+00 Eral1
Distance traveled after self-admin 7.49 1 0 0 0 1e+00 Eral1
Delta time in open arm before/after self-admin 8.04 1 0 0 0 1e+00 Eral1
Extinction: sum of active levers before priming 8.22 1 0 0 0 1e+00 Eral1
Active lever presses in extinction session 6 20.19 1 0 0 0 1e+00 Eral1
Delta distance traveled before/after self-admin 8.53 1 0 0 0 1e+00 Eral1
Delta ambulatory time before/after self-admin 37.49 1 1 100 0 1e+00 Eral1
Time in open arm after self-admin 10.52 1 0 0 0 1e+00 Eral1
Time to tail flick, vehicle, before self-admin 10.06 1 0 0 0 1e+00 Eral1
Time to tail flick, vehicle, after self-admin 4.88 1 0 0 0 1e+00 Eral1
Ambulatory time before self-admin 49.07 1 1 100 0 1e+00 Eral1
Ambulatory time after self-admin 6.62 1 0 0 0 1e+00 Eral1
Total heroin consumption 3.34 1 0 0 0 1e+00 Eral1
Area under the delay curve 45.55 1 1 100 0 1e+00 Eral1
Delay disc. indifference point, 16s delay 63.86 1 1 100 0 1e+00 Eral1
Delay disc. indifference point, 24s delay 9.47 1 0 0 0 1e+00 Eral1
Delay disc. indifference point, 4s delay 6.47 1 0 0 0 1e+00 Eral1
Delay disc. indifference point, 8s delay 71.89 1 1 100 0 1e+00 Eral1
Delay discount exponential model param 36.26 1 1 100 0 1e+00 Eral1
Delay discount hyperbolic model param 29.71 1 1 100 0 1e+00 Eral1
Rest time, locomotor task time 1 15.21 1 0 0 0 1e+00 Eral1
Distance moved, locomotor task time 1 3.68 1 0 0 0 1e+00 Eral1
Time >=10cm from walls, locomotor time 2 39.82 1 1 100 0 1e+00 Eral1
Rest time, locomotor task time 2 5.56 1 0 0 0 1e+00 Eral1
Distance moved, locomotor task time 2 13.4 1 0 0 0 1e+00 Eral1
Vertical activity count, locomotor time 2 8.68 1 0 0 0 1e+00 Eral1
Weight adjusted by age 3.44 1 0 0 0 1e+00 Eral1
Locomotion in novel chamber post-restriction 13.53 1 0 0 0 1e+00 Eral1
Food seeking constrained by brief footshock 13.98 1 0 0 0 1e+00 Eral1
Seeking ratio, punishment vs. effort 10.23 1 0 0 0 1e+00 Eral1
Run reversals in cocaine runway, males 48.09 1 1 100 0 1e+00 Eral1
Latency to leave start box in cocaine runway 12.57 1 0 0 0 1e+00 Eral1
Latency to leave start box in cocaine runway, M 38.49 1 1 100 0 1e+00 Eral1

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.24
Adipose alternative TSS 0 0 1.1
Adipose gene expression 1 0 1.11
Adipose isoform ratio 0 0 1.17
Adipose intron excision ratio 0 0 1.19
Adipose mRNA stability 0 0 1.14
BLA alternative polyA 0 0 1.25
BLA alternative TSS 0 0 1.12
BLA gene expression 0 0 1.18
BLA isoform ratio 0 0 1.14
BLA intron excision ratio 0 0 1.21
BLA mRNA stability 0 0 1.1
Brain alternative polyA 0 0 1.16
Brain alternative TSS 0 0 1.27
Brain gene expression 0 0 1.14
Brain isoform ratio 0 0 1.15
Brain intron excision ratio 0 0 1.19
Brain mRNA stability 0 0 1.1
Eye alternative polyA 0 0 0.86
Eye alternative TSS 0 0 0.99
Eye gene expression 0 0 1.24
Eye isoform ratio 0 0 1.15
Eye intron excision ratio 0 0 1.19
Eye mRNA stability 0 0 0.93
IL alternative polyA 0 0 1.16
IL alternative TSS 0 0 1.28
IL gene expression 0 0 1.19
IL isoform ratio 0 0 1.18
IL intron excision ratio 0 0 1.24
IL mRNA stability 0 0 1.11
LHb alternative polyA 0 0 1.39
LHb alternative TSS 0 0 1.11
LHb gene expression 0 0 1.21
LHb isoform ratio 0 0 1.24
LHb intron excision ratio 0 0 1.38
LHb mRNA stability 0 0 1.1
Liver alternative polyA 0 0 1.33
Liver alternative TSS 0 0 1.18
Liver gene expression 0 0 1.14
Liver isoform ratio 0 0 1.24
Liver intron excision ratio 0 0 1.15
Liver mRNA stability 0 0 1.09
NAcc alternative polyA 0 0 1.19
NAcc alternative TSS 0 0 1.13
NAcc gene expression 0 0 1.14
NAcc isoform ratio 0 0 1.11
NAcc intron excision ratio 0 0 1.19
NAcc mRNA stability 0 0 1.12
OFC alternative polyA 0 0 1.06
OFC alternative TSS 0 0 1.43
OFC gene expression 0 0 1.18
OFC isoform ratio 0 0 1.14
OFC intron excision ratio 0 0 1.37
OFC mRNA stability 0 0 1.13
PL alternative polyA 0 0 1.17
PL alternative TSS 0 0 1.06
PL gene expression 0 0 1.16
PL isoform ratio 0 0 1.13
PL intron excision ratio 0 0 1.26
PL mRNA stability 0 0 1.06